Cytek Biosciences, Inc. (CTKB) quarterly income statement — complete revenue, gross profit & net income history
| Metric | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 | Q2'23 | Q1'23 | Q4'22 | Q3'22 | Q2'22 | Q1'22 | Q4'21 | Q3'21 | Q2'21 |
|---|
| Sales/Revenue | 44.13M | 62.14M | 52.29M | 45.6M | 41.46M | 57.48M | 51.5M | 46.62M | 44.86M | 58.23M | 48M | 49.69M | 37.09M | 48.34M | 40.48M | 40.16M | 35.06M | 38.89M | 34.38M | 30.41M |
| Revenue Growth % | 6.46% | 8.12% | 1.54% | -2.18% | -7.59% | -1.3% | 7.29% | -6.19% | 20.96% | 20.48% | 18.59% | 23.74% | 5.77% | 24.28% | 17.75% | 32.07% | 44.46% | 27.03% | - | - |
| Cost of Goods Sold | 22.88M | 29.26M | 24.74M | 21.73M | 21.3M | 23.82M | 22.5M | 21.18M | 21.85M | 25.18M | 20.82M | 21.53M | 16.05M | 18.96M | 13.62M | 15.6M | 14.89M | 15.26M | 13.1M | 10.66M |
| COGS % of Revenue | 51.84% | 47.08% | 47.31% | 47.66% | 51.38% | 41.45% | 43.68% | 45.44% | 48.7% | 43.25% | 43.38% | 43.33% | 43.28% | 39.23% | 33.64% | 38.84% | 42.46% | 39.23% | 38.11% | 35.07% |
| Gross Profit | 21.25M | 32.88M | 27.55M | 23.87M | 20.16M | 33.65M | 29M | 25.44M | 23.01M | 33.05M | 27.18M | 28.16M | 21.04M | 29.37M | 26.86M | 24.56M | 20.18M | 23.64M | 21.28M | 19.75M |
| Gross Margin % | 48.16% | 52.92% | 52.69% | 52.34% | 48.62% | 58.55% | 56.32% | 54.56% | 51.3% | 56.75% | 56.62% | 56.67% | 56.72% | 60.77% | 66.36% | 61.16% | 57.54% | 60.77% | 61.89% | 64.93% |
| Gross Profit Growth % | 5.44% | -2.28% | -5.01% | -6.17% | -12.41% | 1.83% | 6.72% | -9.68% | 9.39% | 12.51% | 1.18% | 14.66% | 4.27% | 24.28% | 26.25% | 24.39% | 39.29% | 21.53% | - | - |
| Operating Expenses | 39.72M | 38.48M | 36.74M | 34.49M | 35.13M | 30.67M | 33.25M | 33.96M | 33.75M | 33.19M | 33.6M | 37.29M | 33.2M | 29.29M | 25.5M | 25.45M | 22.53M | 22.32M | 18.38M | 15.93M |
| OpEx % of Revenue | 89.99% | 61.92% | 70.26% | 75.63% | 84.74% | 53.35% | 64.57% | 72.86% | 75.23% | 56.99% | 70% | 75.04% | 89.52% | 60.6% | 63% | 63.38% | 64.27% | 57.38% | 53.47% | 52.4% |
| Selling, General & Admin | 30.11M | 29.52M | 27.79M | 25.66M | 25.41M | 20.94M | 23.37M | 23.96M | 23.95M | 22.32M | 22.43M | 25.15M | 23.23M | 19.54M | 16.85M | 17.02M | 14.51M | 15.24M | 12.3M | 9.74M |
| SG&A % of Revenue | 68.23% | 47.5% | 53.14% | 56.28% | 61.29% | 36.44% | 45.38% | 51.4% | 53.39% | 38.32% | 46.72% | 50.62% | 62.62% | 40.43% | 41.63% | 42.37% | 41.38% | 39.19% | 35.79% | 32.03% |
| Research & Development | 9.6M | 8.96M | 8.96M | 8.83M | 9.72M | 9.72M | 9.88M | 10M | 9.8M | 10.87M | 11.17M | 12.14M | 9.97M | 9.75M | 8.65M | 8.44M | 8.03M | 7.08M | 6.08M | 6.19M |
| R&D % of Revenue | 21.76% | 14.42% | 17.13% | 19.35% | 23.46% | 16.92% | 19.19% | 21.45% | 21.84% | 18.66% | 23.27% | 24.42% | 26.89% | 20.17% | 21.37% | 21.01% | 22.89% | 18.19% | 17.68% | 20.37% |
| Other Operating Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -18.46M | -5.59M | -9.19M | -10.62M | -14.97M | 2.99M | -4.25M | -8.53M | -10.73M | -137K | -6.42M | -9.13M | -12.16M | 84K | 1.36M | -891K | -2.36M | 1.32M | 2.9M | 3.81M |
| Operating Margin % | -41.83% | -9% | -17.58% | -23.3% | -36.12% | 5.2% | -8.25% | -18.29% | -23.93% | -0.24% | -13.38% | -18.37% | -32.79% | 0.17% | 3.36% | -2.22% | -6.72% | 3.39% | 8.43% | 12.53% |
| Operating Income Growth % | -23.29% | -287.34% | -116.38% | -24.59% | -39.51% | 2279.56% | 33.83% | 6.57% | 11.74% | -263.1% | -572.06% | -924.35% | -415.99% | -93.62% | -53.05% | -123.38% | -308.22% | -83.28% | - | - |
| EBITDA | -15.65M | -2.55M | -6.13M | -7.64M | -12.09M | 5.73M | -1.44M | -6.05M | -8.27M | 2.29M | -3.86M | -7.51M | -11.16M | 1.95M | 2.13M | -25K | -887K | 2M | 3.09M | 4.01M |
| EBITDA Margin % | -35.46% | -4.11% | -11.73% | -16.74% | -29.17% | 9.96% | -2.79% | -12.97% | -18.44% | 3.93% | -8.04% | -15.11% | -30.09% | 4.03% | 5.26% | -0.06% | -2.53% | 5.15% | 8.98% | 13.19% |
| EBITDA Growth % | -29.44% | -144.54% | -326.13% | -26.28% | -46.13% | 150.31% | 62.73% | 19.45% | 25.87% | 17.45% | -281.18% | -29928% | -1158.29% | -2.7% | -30.95% | -100.62% | -168.28% | -75.08% | - | - |
| D&A (Non-Cash Add-back) | 2.81M | 3.04M | 3.06M | 2.99M | 2.88M | 2.74M | 2.81M | 2.48M | 2.46M | 2.42M | 2.56M | 1.62M | 1M | 1.86M | 771K | 866K | 1.47M | 685K | 189K | 201K |
| EBIT | -18.46M | -3.31M | -7.28M | -6.36M | -10.97M | -5.19M | 276K | -7.05M | -8.55M | 4.5M | -3.59M | -6.19M | -8.37M | 4.8M | 2.5M | -754K | -2.71M | 936K | 2.52M | 3.7M |
| Net Interest Income | 525K | -145K | 79K | 141K | 217K | 6.15M | 1.31M | 1.28M | 918K | 1.05M | 1.03M | 792K | 1.47M | 1.94M | 935K | -256K | -572K | -474K | -429K | -424K |
| Interest Income | 787K | 580K | 573K | 555K | 508K | 6.15M | 1.43M | 1.42M | 1.36M | 1.45M | 1.62M | 1.2M | 2.14M | 2.63M | 1.58M | 391K | 18K | 18K | 12K | 9K |
| Interest Expense | 262K | 725K | 494K | 414K | 291K | 0 | 119K | 134K | 441K | 394K | 595K | 409K | 673K | 687K | 649K | 647K | 590K | 492K | 441K | 433K |
| Other Income/Expense | 1.09M | 1.56M | 1.42M | 3.85M | 3.71M | 7.34M | 4.41M | 1.34M | 1.74M | 4.25M | 2.23M | 2.53M | 3.12M | 4.03M | 490K | -510K | -946K | -873K | -822K | -544K |
| Pretax Income | -17.37M | -4.03M | -7.77M | -6.78M | -11.27M | 10.32M | 157K | -7.19M | -8.99M | 4.11M | -4.18M | -6.59M | -9.04M | 4.11M | 1.85M | -1.4M | -3.3M | 444K | 2.08M | 3.27M |
| Pretax Margin % | -39.36% | -6.49% | -14.86% | -14.86% | -27.18% | 17.96% | 0.3% | -15.42% | -20.05% | 7.06% | -8.72% | -13.27% | -24.37% | 8.51% | 4.57% | -3.49% | -9.42% | 1.14% | 6.04% | 10.74% |
| Income Tax | 1.49M | 40.05M | -2.29M | -1.19M | 136K | 680K | -784K | 3.25M | -2.82M | -1.39M | 2.27M | -2.21M | -2.23M | 396K | 224K | -699K | -1.15M | 1.61M | 655K | 597K |
| Effective Tax Rate % | -8.59% | -993.43% | 29.49% | 17.59% | -1.21% | 6.59% | -499.36% | -45.2% | 31.4% | -33.86% | -54.27% | 33.46% | 24.7% | 9.63% | 12.11% | 49.89% | 34.67% | 362.39% | 31.57% | 18.27% |
| Net Income | -18.87M | -44.08M | -5.48M | -5.58M | -11.4M | 9.64M | 941K | -10.43M | -6.17M | 5.5M | -6.46M | -4.39M | -6.81M | 3.53M | 1.67M | -598K | -2.02M | -1.19M | 1.42M | 2.67M |
| Net Margin % | -42.75% | -70.93% | -10.48% | -12.24% | -27.5% | 16.78% | 1.83% | -22.38% | -13.75% | 9.45% | -13.45% | -8.83% | -18.35% | 7.3% | 4.12% | -1.49% | -5.76% | -3.06% | 4.13% | 8.78% |
| Net Income Growth % | -65.46% | -557.08% | -682.15% | 46.49% | -84.83% | 75.23% | 114.58% | -137.78% | 9.37% | 55.94% | -487.51% | -633.78% | -236.81% | 396.31% | 17.32% | -122.4% | -2081.37% | -121.27% | - | - |
| Net Income (Continuing) | -18.87M | -44.08M | -5.48M | -5.58M | -11.4M | 9.64M | 941K | -10.43M | -6.17M | 5.5M | -6.46M | -4.39M | -6.81M | 3.72M | 1.63M | -702K | -2.16M | -1.17M | 1.42M | 2.67M |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 251K | 62K | 102K | 206K | 343K | 315K | 315K |
| EPS (Diluted) | -0.15 | -0.34 | -0.04 | -0.04 | -0.09 | 0.07 | 0.01 | -0.08 | -0.05 | 0.04 | -0.05 | -0.03 | -0.05 | 0.03 | 0.01 | -0.00 | -0.02 | 0.00 | 0.01 | 0.02 |
| EPS Growth % | -66.67% | -568.32% | - | 44.58% | -91.08% | 72.45% | 114.98% | -145.82% | 6.18% | 63.18% | -495% | - | -211.8% | - | -14.29% | -121.57% | - | -95.6% | - | - |
| EPS (Basic) | -0.15 | -0.34 | -0.04 | -0.04 | -0.09 | 0.07 | 0.01 | -0.08 | -0.05 | 0.04 | -0.05 | -0.03 | -0.05 | 0.03 | 0.01 | -0.00 | -0.02 | 0.00 | 0.01 | 0.02 |
| Diluted Shares Outstanding | 128.7M | 128.17M | 127.55M | 126.93M | 128.34M | 129.21M | 132.79M | 131.44M | 130.92M | 130.71M | 136.17M | 135.92M | 135.49M | 137.03M | 138.71M | 134.4M | 133.9M | 113.64M | 113.64M | 130.81M |
| Basic Shares Outstanding | 128.7M | 128.17M | 127.55M | 126.93M | 128.34M | 129.21M | 131M | 131.44M | 130.92M | 130.71M | 136.17M | 135.92M | 135.49M | 135M | 134.71M | 134.4M | 133.9M | 108.32M | 108.32M | 130.81M |
| Dividend Payout Ratio | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |